News and Announcements
QHeart Medical – First Australian Private Company to Receive AISRF Support
- Published January 12, 2018 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- QHeart Medical (BioQ Devices Pty Ltd) only private research organisation to be awarded prestigious Australia India strategic research fund (AISRF) grant of $1Million.
- QHeart Medical participated in the Wholesale Investor Life Sciences event in Singapore to connect with Investors in the Asian region.
- QHeart Medical prepares for investment and showcases on the Wholesale Investor site.
- Winners of the QUT J&J Partnering Office pitch session (Dec 2017) with free entry into the 2018 MTPConnect BridgeTech Commercialisation program.
- World First Study: QHeart Medical successfully implanted their “pumpless” BioQ Cardiac Assist device using a minimally invasive procedure (MIS) on pigs QUT MERF, Brisbane (Dec 2017), avoiding open chest surgery and allow faster patient recovery.
QHeart Medical in collaboration with Frontier Lifeline Hospital, UNSW and QUT, are developing a revolutionary heart failure treatment device for heart failure which is highly unserved with cost effective and preventative treatment options and carries a massive economic burden to society. QHeart’s cost effective cardiac assist device, the BioQ CA, requires no pump or control system, and is designed to improve Quality of Life and reduce healthcare costs for millions of unserved patients worldwide. The Federal Government is supporting the program with the awarding of the prestigious Australia-India Strategic Fund (AISRF) grant.
In Oct’2017, QHeart Medical team presented at the Wholesale Investor Life Science event in Singapore to develop investor contacts.
In Dec’2017, QHeart Medical successfully placed the BioQ Cardiac Assist Device using minimally invasive procedure (MIS) on Pigs aorta at MERF, QUT, Brisbane. This will minimise the operating procedure time and assist faster patient recovery, and reduce treatment costs for this revolutionary affordable therapy.
In 2018, QHeart Medical is seeking further capital to accelerate the commercialisation activities of the BioQ CA heart failure treatment.
About QHeart Medical
QHeart Medical is commercialising a revolutionary heart failure treatment device for heart failure and hypertension which are highly unserved with cost-effective and preventative treatment options and carry a massive economic burden to society.
Our cost-effective self-powered cardiac assist device, the BioQ CA, requires no pump or control system, and aims to improve Quality of Life and reduce healthcare costs for millions of unserved patients worldwide.
Company Updates
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Everything is now competing for the same dollar
Key takeaways As recently as 2022, Germany and Japan could borrow for 30 years at close to zero. That world is gone, and AI is now bidding for what is left. Over the past fortnight, I listened to founders, operators and allocators describe where their industries are heading. They covered four very different frontiers. Each […]
Australia has not held 90 days of fuel since 2012. The fix may start at a sewage plant.
A decommissioned council treatment site in Bundaberg is being built into a $188.9 million biorefinery. Its managing director is candid that the largest revenue line is not yet contracted. Australia has not met its international 90-day fuel reserve obligation since 2012. Around 90 per cent of the country’s liquid fuel is imported. Andy Whitmore, Managing […]
Backed By Leading Investment Groups and Family Offices
